AKT1 and neoplasm: The results showed that the drugs ABT.263, AKT.inhibitor.VIII, AZD6244 and BMS.708163 had higher IC50 values in tumor cells in the high-risk group, while the other drugs had higher IC50 values in tumor cells in the low-risk group (Figure 10O).